Pharmaceutical

Record number of respiratory syncytial virus (RSV) designations awarded in 2022

In 2022, global regulatory authorities awarded a record ten review designations for respiratory syncytial virus (RSV)-indicated drugs.

Sep 9, 2023 - 20:00
Record number of respiratory syncytial virus (RSV) designations awarded in 2022
In 2022, global regulatory authorities awarded a record ten review designations for respiratory syncytial virus (RSV)-indicated drugs.
Read the original article

Tags:

Previous Article

Eloxx moves ahead with plans with gene therapy for rare kidney disorder

Next Article

Otsuka and ShapeTX to develop gene therapies for eye diseases

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Beating the Big C

Beating the Big C

Apr 16, 2023

How a six-in-one vaccine could soon help the world get rid of polio for good

How a six-in-one vaccine could soon help the world get ...

Jun 24, 2023

Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023

Revenue growth for 13 of top 20 biopharmas with obesity...

Aug 1, 2024